BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22825514)

  • 1. Downregulating PRL-3 inhibit migration and invasion of lung cancer cell via RhoA and mDia1.
    Jian M; Nan L; Guocheng J; Qingfu Z; Xueshan Q; Enhua W
    Tumori; 2012; 98(3):370-6. PubMed ID: 22825514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated phosphatase of regenerating liver 3 (PRL-3) promotes cytoskeleton reorganization, cell migration and invasion in endometrial stromal cells from endometrioma.
    Zhan H; Ma J; Ruan F; Bedaiwy MA; Peng B; Wu R; Lin J
    Hum Reprod; 2016 Apr; 31(4):723-33. PubMed ID: 26874360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer.
    Ming J; Liu N; Gu Y; Qiu X; Wang EH
    Pathology; 2009 Feb; 41(2):118-26. PubMed ID: 19152186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ; Keller PJ; Cox AD
    Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
    Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
    Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion.
    Wang Y; Lazo JS
    Oncogene; 2012 Feb; 31(7):818-27. PubMed ID: 21765462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion.
    Gari HH; DeGala GD; Ray R; Lucia MS; Lambert JR
    Cancer Lett; 2016 Oct; 380(2):505-512. PubMed ID: 27452906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatase of regenerating liver-1 promotes cell migration and invasion and regulates filamentous actin dynamics.
    Nakashima M; Lazo JS
    J Pharmacol Exp Ther; 2010 Aug; 334(2):627-33. PubMed ID: 20484558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of RhoA and its effectors ROCK and mDia1 in the modulation of deformation-induced FAK, ERK, p38, and MLC motogenic signals in human Caco-2 intestinal epithelial cells.
    Chaturvedi LS; Marsh HM; Basson MD
    Am J Physiol Cell Physiol; 2011 Nov; 301(5):C1224-38. PubMed ID: 21849669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells.
    Liu H; Al-aidaroos AQ; Wang H; Guo K; Li J; Zhang HF; Zeng Q
    BMC Cancer; 2013 Feb; 13():80. PubMed ID: 23418787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition.
    Lin SY; Lee YX; Yu SL; Chang GC; Chen JJ
    Oncotarget; 2016 Apr; 7(16):21799-811. PubMed ID: 26967563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRL-3 promotes migration and invasion and is associated with poor prognosis in salivary adenoid cystic carcinoma.
    Dong Q; Ding X; Chang B; Wang H; Wang A
    J Oral Pathol Med; 2016 Feb; 45(2):111-8. PubMed ID: 26041460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression.
    Yoon JH; Choi WS; Kim O; Choi BJ; Nam SW; Lee JY; Park WS
    Gastric Cancer; 2017 Mar; 20(2):274-285. PubMed ID: 27250838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.
    Chu ZH; Liu L; Zheng CX; Lai W; Li SF; Wu H; Zeng YJ; Zhao HY; Guan YF
    Chin Med J (Engl); 2011 Nov; 124(22):3778-85. PubMed ID: 22340241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
    Zhou J; Wang S; Lu J; Li J; Ding Y
    Int J Cancer; 2009 Apr; 124(8):1879-86. PubMed ID: 19101992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of PRL-3 regulates proliferation and invasion of breast cancer cells in vitro.
    Radke I; Götte M; Smollich M; Scharle N; Kiesel L; Wülfing P
    Arch Gynecol Obstet; 2017 Dec; 296(6):1153-1160. PubMed ID: 28980126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo.
    Matsukawa Y; Semba S; Kato H; Koma Y; Yanagihara K; Yokozaki H
    Pathobiology; 2010; 77(3):155-62. PubMed ID: 20516731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expressions and significances of PRL-3 and RhoC in A549 cell].
    ZHANG P; ZHANG Z; LI X; LEI J; SU K; LI X; WANG X
    Zhongguo Fei Ai Za Zhi; 2010 Dec; 13(12):1160-4. PubMed ID: 21159255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3.
    Li Z; Cao Y; Jie Z; Liu Y; Li Y; Li J; Zhu G; Liu Z; Tu Y; Peng G; Lee DW; Park SS
    Cancer Lett; 2012 Oct; 323(1):41-47. PubMed ID: 22469786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN.
    Xiong J; Li Z; Zhang Y; Li D; Zhang G; Luo X; Jie Z; Liu Y; Cao Y; Le Z; Tan S; Zou W; Gong P; Qiu L; Li Y; Wang H; Chen H
    Oncol Rep; 2016 Oct; 36(4):1819-28. PubMed ID: 27572739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.